{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T21:03:23Z","timestamp":1788642203987,"version":"build-2803163510"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["No. 82160278"],"award-info":[{"award-number":["No. 82160278"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004607","name":"Natural Science Foundation of Guangxi Province","doi-asserted-by":"publisher","award":["No. 2023GXNSFAA026209"],"award-info":[{"award-number":["No. 2023GXNSFAA026209"]}],"id":[{"id":"10.13039\/501100004607","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003093","name":"Ministry of Higher Education, Malaysia","doi-asserted-by":"publisher","award":["FRGS\/1\/2021\/WAB13\/UCSI\/02\/1 and FRGS\/1\/2021\/SKK06\/UCSI\/02\/4"],"award-info":[{"award-number":["FRGS\/1\/2021\/WAB13\/UCSI\/02\/1 and FRGS\/1\/2021\/SKK06\/UCSI\/02\/4"]}],"id":[{"id":"10.13039\/501100003093","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100031258","name":"UCSI University","doi-asserted-by":"publisher","award":["REIG-FPS-2023\/043"],"award-info":[{"award-number":["REIG-FPS-2023\/043"]}],"id":[{"id":"10.13039\/100031258","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Oncol"],"DOI":"10.1007\/s12032-025-02696-3","type":"journal-article","created":{"date-parts":[[2025,4,4]],"date-time":"2025-04-04T00:55:45Z","timestamp":1743728145000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Mcl-1 is an important target protein for kaempferol from persimmon leaves in sensitizing ABT-199 to induce apoptosis in hepatoma cancer cells"],"prefix":"10.1007","volume":"42","author":[{"given":"Li","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu Dong","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue Ping","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu Zhao","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chau Ling","family":"Tham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rohana","family":"Yusof","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Si","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming Tatt","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,1]]},"reference":[{"issue":"1","key":"2696_CR1","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3322\/caac.21763","volume":"73","author":"RL Siegel","year":"2023","unstructured":"Siegel RL, Miller KD, Wagle NS, Jemal A. Cancer statistics, 2023. CA Cancer J Clin. 2023;73(1):17\u201348. https:\/\/doi.org\/10.3322\/caac.21763.","journal-title":"CA Cancer J Clin"},{"issue":"6","key":"2696_CR2","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1007\/s00705-021-04981-8","volume":"166","author":"NA Ali","year":"2021","unstructured":"Ali NA, Hamdy NM, Gibriel AA, El Mesallamy HO. Investigation of the relationship between CTLA4 and the tumor suppressor RASSF1A and the possible mediating role of STAT4 in a cohort of Egyptian patients infected with hepatitis C virus with and without hepatocellular carcinoma. Arch Virol. 2021;166(6):1643\u201351. https:\/\/doi.org\/10.1007\/s00705-021-04981-8.","journal-title":"Arch Virol"},{"issue":"11","key":"2696_CR3","doi-asserted-by":"publisher","first-page":"3347","DOI":"10.1007\/s00705-017-3498-7","volume":"162","author":"SS Youssef","year":"2017","unstructured":"Youssef SS, Hamdy NM. SOCS1 and pattern recognition receptors: TLR9 and RIG-I; novel haplotype associations in Egyptian fibrotic\/cirrhotic patients with HCV genotype 4. Arch Virol. 2017;162(11):3347\u201354. https:\/\/doi.org\/10.1007\/s00705-017-3498-7.","journal-title":"Arch Virol"},{"issue":"1","key":"2696_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jncc.2022.02.002","volume":"2","author":"R Zheng","year":"2022","unstructured":"Zheng R, Zhang S, Zeng H, Wang S, Sun K, Chen R, Li L, Wei W, He J. Cancer incidence and mortality in China, 2016. J Natl Cancer Cent. 2022;2(1):1\u20139. https:\/\/doi.org\/10.1016\/j.jncc.2022.02.002.","journal-title":"J Natl Cancer Cent"},{"issue":"5","key":"2696_CR5","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1002\/hep.32740","volume":"77","author":"R Donne","year":"2023","unstructured":"Donne R, Lujambio A. The liver cancer immune microenvironment: therapeutic implications for hepatocellular carcinoma. Hepatology. 2023;77(5):1773\u201396. https:\/\/doi.org\/10.1002\/hep.32740.","journal-title":"Hepatology"},{"issue":"9","key":"2696_CR6","doi-asserted-by":"publisher","first-page":"3233","DOI":"10.3390\/ijms21093233","volume":"21","author":"K Bukowski","year":"2020","unstructured":"Bukowski K, Kciuk M, Kontek R. Mechanisms of multidrug resistance in cancer chemotherapy. Int J Mol Sci. 2020;21(9):3233. https:\/\/doi.org\/10.3390\/ijms21093233.","journal-title":"Int J Mol Sci"},{"issue":"34","key":"2696_CR7","doi-asserted-by":"publisher","first-page":"7645","DOI":"10.3748\/wjg.v22.i34.7645","volume":"22","author":"S Colagrande","year":"2016","unstructured":"Colagrande S, Inghilesi AL, Aburas S, Taliani GG, Nardi C, Marra F. Challenges of advanced hepatocellular carcinoma. World J Gastroenterol. 2016;22(34):7645\u201359. https:\/\/doi.org\/10.3748\/wjg.v22.i34.7645.","journal-title":"World J Gastroenterol"},{"issue":"17","key":"2696_CR8","doi-asserted-by":"publisher","first-page":"15349","DOI":"10.1007\/s00432-023-05313-w","volume":"149","author":"R Hammad","year":"2023","unstructured":"Hammad R, Eldosoky MA, Elmadbouly AA, Aglan RB, AbdelHamid SG, Zaky S, Ali E, Abd El Hakam FE, Mosaad AM, Abdelmageed NA, Kotb FM, Kotb HG, Hady AA, Abo-Elkheir OI, Kujumdshiev S, Sack U, Lambert C, Hamdy NM. Monocytes subsets altered distribution and dysregulated plasma hsa-miR-21\u20135p and hsa-miR-155\u20135p in HCV-linked liver cirrhosis progression to hepatocellular carcinoma. J Cancer Res Clin Oncol. 2023;149(17):15349\u201364. https:\/\/doi.org\/10.1007\/s00432-023-05313-w.","journal-title":"J Cancer Res Clin Oncol"},{"issue":"1","key":"2696_CR9","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/nrm3722","volume":"15","author":"PE Czabotar","year":"2014","unstructured":"Czabotar PE, Lessene G, Strasser A, Adams JM. Control of apoptosis by the BCL-2 protein family: implications for physiology and therapy. Nat Rev Mol Cell Biol. 2014;15(1):49\u201363. https:\/\/doi.org\/10.1038\/nrm3722.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"1","key":"2696_CR10","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.jhep.2005.09.010","volume":"44","author":"W Sieghart","year":"2006","unstructured":"Sieghart W, Losert D, Strommer S, Cejka D, Schmid K, Rasoul-Rockenschaub S, Bodingbauer M, Crevenna R, Monia BP, Peck-Radosavljevic M, Wacheck V. Mcl-1 overexpression in hepatocellular carcinoma: a potential target for antisense therapy. J Hepatol. 2006;44(1):151\u20137. https:\/\/doi.org\/10.1016\/j.jhep.2005.09.010.","journal-title":"J Hepatol"},{"issue":"2","key":"2696_CR11","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1080\/13543776.2017.1249848","volume":"27","author":"L Chen","year":"2017","unstructured":"Chen L, Fletcher S. Mcl-1 inhibitors: a patent review. Expert Opin Ther Pat. 2017;27(2):163\u201378. https:\/\/doi.org\/10.1080\/13543776.2017.1249848.","journal-title":"Expert Opin Ther Pat"},{"issue":"1","key":"2696_CR12","doi-asserted-by":"publisher","first-page":"2177","DOI":"10.1038\/s41467-022-29824-1","volume":"13","author":"M Troiani","year":"2022","unstructured":"Troiani M, Colucci M, D\u2019Ambrosio M, Guccini I, Pasquini E, Varesi A, Valdata A, Mosole S, Revandkar A, Attanasio G, Rinaldi A, Rinaldi A, Bolis M, Cippa P, Alimonti A. Single-cell transcriptomics identifies Mcl-1 as a target for senolytic therapy in cancer. Nat Commun. 2022;13(1):2177. https:\/\/doi.org\/10.1038\/s41467-022-29824-1.","journal-title":"Nat Commun"},{"issue":"12","key":"2696_CR13","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1021\/acsmedchemlett.6b00302","volume":"7","author":"Y Lu","year":"2016","unstructured":"Lu Y, Wu S, Yue Y, He S, Li J, Tang J, Wang W, Zhou HB. Gossypol with hydrophobic linear esters exhibits enhanced antitumor activity as an inhibitor of antiapoptotic proteins. ACS Med Chem Lett. 2016;7(12):1185\u201390. https:\/\/doi.org\/10.1021\/acsmedchemlett.6b00302.","journal-title":"ACS Med Chem Lett"},{"issue":"14","key":"2696_CR14","doi-asserted-by":"publisher","first-page":"3163","DOI":"10.1021\/jm070383c","volume":"50","author":"G Tang","year":"2007","unstructured":"Tang G, Ding K, Nikolovska-Coleska Z, Yang CY, Qiu S, Shangary S, Wang R, Guo J, Gao W, Meagher J, Stuckey J, Krajewski K, Jiang S, Roller PP, Wang S. Structure-based design of flavonoid compounds as a new class of small-molecule inhibitors of the anti-apoptotic Bcl-2 proteins. J Med Chem. 2007;50(14):3163\u20136. https:\/\/doi.org\/10.1021\/jm070383c.","journal-title":"J Med Chem"},{"issue":"1","key":"2696_CR15","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/s13045-021-01079-1","volume":"14","author":"H Wang","year":"2021","unstructured":"Wang H, Guo M, Wei H, Chen Y. Targeting MCL-1 in cancer: current status and perspectives. J Hematol Oncol. 2021;14(1):67. https:\/\/doi.org\/10.1186\/s13045-021-01079-1.","journal-title":"J Hematol Oncol"},{"issue":"2","key":"2696_CR16","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1038\/nm.3048","volume":"19","author":"AJ Souers","year":"2013","unstructured":"Souers AJ, Leverson JD, Boghaert ER, Ackler SL, Catron ND, Chen J, Dayton BD, Ding H, Enschede SH, Fairbrother WJ, Huang DC, Hymowitz SG, Jin S, Khaw SL, Kovar PJ, Lam LT, Lee J, Maecker HL, Marsh KC, Mason KD, Mitten MJ, Nimmer PM, Oleksijew A, Park CH, Park CM, Phillips DC, Roberts AW, Sampath D, Seymour JF, Smith ML, Sullivan GM, Tahir SK, Tse C, Wendt MD, Xiao Y, Xue JC, Zhang H, Humerickhouse RA, Rosenberg SH, Elmore SW. ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets. Nat Med. 2013;19(2):202\u20138. https:\/\/doi.org\/10.1038\/nm.3048.","journal-title":"Nat Med"},{"issue":"9","key":"2696_CR17","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1007\/s40265-016-0596-x","volume":"76","author":"ED Deeks","year":"2016","unstructured":"Deeks ED. Venetoclax: first global approval. Drugs. 2016;76(9):979\u201387. https:\/\/doi.org\/10.1007\/s40265-016-0596-x.","journal-title":"Drugs"},{"key":"2696_CR18","doi-asserted-by":"publisher","first-page":"5274598","DOI":"10.1155\/2019\/5274598","volume":"1","author":"Y Zhou","year":"2019","unstructured":"Zhou Y, Li K, Li F, Han S, Wang Y, Li X. Doxorubicin and ABT-199 coencapsulated nanocarriers for targeted delivery and synergistic treatment against hepatocellular carcinoma. J Nanomater. 2019;1:5274598. https:\/\/doi.org\/10.1155\/2019\/5274598.","journal-title":"J Nanomater"},{"key":"2696_CR19","doi-asserted-by":"publisher","first-page":"1032069","DOI":"10.3389\/fphar.2022.1032069","volume":"13","author":"L Chen","year":"2022","unstructured":"Chen L, Jiang X, Gao S, Liu X, Gao Y, Kow ASF, Tham CL, Lee MT. Sensitization effect of kaempferol from persimmon leaves on HepG2 hepatoma cells with ABT-199 resistance and its molecular mechanisms. Front Pharmacol. 2022;13:1032069. https:\/\/doi.org\/10.3389\/fphar.2022.1032069.","journal-title":"Front Pharmacol"},{"issue":"7277","key":"2696_CR20","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1038\/nature08646","volume":"463","author":"M Schwickart","year":"2010","unstructured":"Schwickart M, Huang X, Lill JR, Liu J, Ferrando R, French DM, Maecker H, O\u2019Rourke K, Bazan F, Eastham-Anderson J, Yue P, Dornan D, Huang DC, Dixit VM. Deubiquitinase USP9X stabilizes MCL1 and promotes tumour cell survival. Nature. 2010;463(7277):103\u20137. https:\/\/doi.org\/10.1038\/nature08646.","journal-title":"Nature"},{"issue":"4","key":"2696_CR21","doi-asserted-by":"publisher","first-page":"2456","DOI":"10.1016\/j.bbrc.2017.12.153","volume":"495","author":"HP Zhang","year":"2018","unstructured":"Zhang HP, Li GQ, Zhang Y, Guo WZ, Zhang JK, Li J, Lv JF, Zhang SJ. Upregulation of Mcl-1 inhibits JQ1-triggered anticancer activity in hepatocellular carcinoma cells. Biochem Biophys Res Commun. 2018;495(4):2456\u201361. https:\/\/doi.org\/10.1016\/j.bbrc.2017.12.153.","journal-title":"Biochem Biophys Res Commun"},{"key":"2696_CR22","doi-asserted-by":"publisher","first-page":"106427","DOI":"10.1016\/j.bioorg.2023.106427","volume":"133","author":"H Atta","year":"2023","unstructured":"Atta H, Alzahaby N, Hamdy NM, Emam SH, Sonousi A, Ziko L. New trends in synthetic drugs and natural products targeting 20S proteasomes in cancers. Bioorg Chem. 2023;133:106427. https:\/\/doi.org\/10.1016\/j.bioorg.2023.106427.","journal-title":"Bioorg Chem"},{"issue":"1","key":"2696_CR23","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1186\/s12935-022-02815-4","volume":"22","author":"MM Anwar","year":"2022","unstructured":"Anwar MM, Albanese C, Hamdy NM, Sultan AS. Rise of the natural red pigment \u201cprodigiosin\u201d as an immunomodulator in cancer. Cancer Cell Int. 2022;22(1):419. https:\/\/doi.org\/10.1186\/s12935-022-02815-4.","journal-title":"Cancer Cell Int"},{"key":"2696_CR24","doi-asserted-by":"publisher","first-page":"1491802","DOI":"10.3389\/fphar.2024.1491802","volume":"15","author":"Q Li","year":"2024","unstructured":"Li Q, Tong Y, Chen J, Xie T. Targeting programmed cell death via active ingredients from natural plants: a promising approach to cancer therapy. Front Pharmacol. 2024;15:1491802. https:\/\/doi.org\/10.3389\/fphar.2024.1491802.","journal-title":"Front Pharmacol"},{"issue":"24","key":"2696_CR25","doi-asserted-by":"publisher","first-page":"13659","DOI":"10.3390\/ijms222413659","volume":"22","author":"M Kubczak","year":"2021","unstructured":"Kubczak M, Szustka A, Rogali\u0144ska M. Molecular targets of natural compounds with anti-cancer properties. Int J Mol Sci. 2021;22(24):13659. https:\/\/doi.org\/10.3390\/ijms222413659.","journal-title":"Int J Mol Sci"},{"issue":"4","key":"2696_CR26","doi-asserted-by":"publisher","first-page":"937","DOI":"10.3390\/plants12040937","volume":"12","author":"A Hossain","year":"2023","unstructured":"Hossain A, Shahidi F. Persimmon leaves: nutritional, pharmaceutical, and industrial potential-a review. Plants (Basel). 2023;12(4):937. https:\/\/doi.org\/10.3390\/plants12040937.","journal-title":"Plants (Basel)."},{"key":"2696_CR27","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.jep.2015.01.007","volume":"163","author":"C Xie","year":"2015","unstructured":"Xie C, Xie Z, Xu X, Yang D. Persimmon (Diospyros kaki L.) leaves: a review on traditional uses, phytochemistry and pharmacological properties. J Ethnopharmacol. 2015;163:229\u201340. https:\/\/doi.org\/10.1016\/j.jep.2015.01.007.","journal-title":"J Ethnopharmacol"},{"issue":"12","key":"2696_CR28","doi-asserted-by":"publisher","first-page":"3603","DOI":"10.1007\/s00277-023-05500-2","volume":"102","author":"X Zheng","year":"2023","unstructured":"Zheng X, Gao H, Lu N, Wang M, Zhang H, Zheng Y, Shen B, Cao Y, Chen X, Zhai W, Wei J, Yang D, Zhang R, Pang A, Feng S, Jiang E, Han M. Efficacy of venetoclax combined with decitabine conditioning regimen for allogeneic hematopoietic stem cell transplantation in high-risk and elderly patients with myeloid neoplasms. Ann Hematol. 2023;102(12):3603\u201311. https:\/\/doi.org\/10.1007\/s00277-023-05500-2.","journal-title":"Ann Hematol"},{"issue":"7","key":"2696_CR29","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1182\/blood.2020008727","volume":"137","author":"S Le Gouill","year":"2021","unstructured":"Le Gouill S, Morschhauser F, Chiron D, Bouabdallah K, Cartron G, Casasnovas O, Bodet-Milin C, Ragot S, Bossard C, Nadal N, Herbaux C, Tessoulin B, Tchernonog E, Rossi C, McCulloch R, Gastinne T, Callanan MB, Rule S. Ibrutinib, obinutuzumab, and venetoclax in relapsed and untreated patients with mantle cell lymphoma: a phase 1\/2 trial. Blood. 2021;137(7):877\u201387. https:\/\/doi.org\/10.1182\/blood.2020008727.","journal-title":"Blood"},{"issue":"3","key":"2696_CR30","doi-asserted-by":"publisher","first-page":"531","DOI":"10.3390\/biomedicines10030531","volume":"10","author":"S Kamran","year":"2022","unstructured":"Kamran S, Sinniah A, Chik Z, Alshawsh MA. Diosmetin exerts synergistic effects in combination with 5-fluorouracil in colorectal cancer cells. Biomedicines. 2022;10(3):531. https:\/\/doi.org\/10.3390\/biomedicines10030531.","journal-title":"Biomedicines"},{"issue":"5","key":"2696_CR31","doi-asserted-by":"publisher","first-page":"842","DOI":"10.3724\/abbs.2023049","volume":"55","author":"Y Lu","year":"2023","unstructured":"Lu Y, Huang P, Li Y, Liu W, Li J, Zhao R, Feng H, Shi C, Cao G. The FBXO32\/ATR\/ATM axis acts as a molecular switch to control the sensitivity of osteosarcoma cells to irradiation through its regulation of EXO1 expression. Acta Biochim Biophys Sin (Shanghai). 2023;55(5):842\u201352. https:\/\/doi.org\/10.3724\/abbs.2023049.","journal-title":"Acta Biochim Biophys Sin (Shanghai)"},{"key":"2696_CR32","doi-asserted-by":"publisher","first-page":"102363","DOI":"10.1016\/j.redox.2022.102363","volume":"54","author":"XC Ni","year":"2022","unstructured":"Ni XC, Wang HF, Cai YY, Yang D, Alolga RN, Liu B, Li J, Huang FQ. Ginsenoside Rb1 inhibits astrocyte activation and promotes transfer of astrocytic mitochondria to neurons against ischemic stroke. Redox Biol. 2022;54:102363. https:\/\/doi.org\/10.1016\/j.redox.2022.102363.","journal-title":"Redox Biol"},{"key":"2696_CR33","doi-asserted-by":"publisher","first-page":"595316","DOI":"10.3389\/fimmu.2020.595316","volume":"11","author":"Z Yi","year":"2020","unstructured":"Yi Z, Wu Y, Zhang W, Wang T, Gong J, Cheng Y, Miao C. Activator-mediated pyruvate kinase M2 activation contributes to endotoxin tolerance by promoting mitochondrial biogenesis. Front Immunol. 2020;11:595316. https:\/\/doi.org\/10.3389\/fimmu.2020.595316.","journal-title":"Front Immunol"},{"issue":"1","key":"2696_CR34","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1080\/07853890.2022.2034931","volume":"54","author":"W Zhu","year":"2022","unstructured":"Zhu W, Li Y, Zhao J, Wang Y, Li Y, Wang Y. The mechanism of triptolide in the treatment of connective tissue disease-related interstitial lung disease based on network pharmacology and molecular docking. Ann Med. 2022;54(1):541\u201352. https:\/\/doi.org\/10.1080\/07853890.2022.2034931.","journal-title":"Ann Med"},{"issue":"4","key":"2696_CR35","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1007\/s11010-022-04546-6","volume":"478","author":"Q Zhang","year":"2023","unstructured":"Zhang Q, Chen L, Gao M, Wang S, Meng L, Guo L. Molecular docking and in vitro experiments verified that kaempferol induced apoptosis and inhibited human HepG2 cell proliferation by targeting BAX, CDK1, and JUN. Mol Cell Biochem. 2023;478(4):767\u201380. https:\/\/doi.org\/10.1007\/s11010-022-04546-6.","journal-title":"Mol Cell Biochem"},{"key":"2696_CR36","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1186\/1476-4598-12-146","volume":"12","author":"H Ren","year":"2013","unstructured":"Ren H, Koo J, Guan B, Yue P, Deng X, Chen M, Khuri FR, Sun SY. The E3 ubiquitin ligases \u03b2-TrCP and FBXW7 cooperatively mediates GSK3-dependent Mcl-1 degradation induced by the Akt inhibitor API-1, resulting in apoptosis. Mol Cancer. 2013;12:146. https:\/\/doi.org\/10.1186\/1476-4598-12-146.","journal-title":"Mol Cancer"},{"issue":"2","key":"2696_CR37","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1158\/0008-5472.Can-09-1947","volume":"70","author":"TC Chou","year":"2010","unstructured":"Chou TC. Drug combination studies and their synergy quantification using the Chou-Talalay method. Cancer Res. 2010;70(2):440\u20136. https:\/\/doi.org\/10.1158\/0008-5472.Can-09-1947.","journal-title":"Cancer Res"},{"issue":"8","key":"2696_CR38","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1038\/sj.cdd.4401260","volume":"10","author":"M Karbowski","year":"2003","unstructured":"Karbowski M, Youle RJ. Dynamics of mitochondrial morphology in healthy cells and during apoptosis. Cell Death Differ. 2003;10(8):870\u201380. https:\/\/doi.org\/10.1038\/sj.cdd.4401260.","journal-title":"Cell Death Differ"},{"issue":"17","key":"2696_CR39","doi-asserted-by":"publisher","first-page":"4440","DOI":"10.1158\/1078-0432.CCR-15-3057","volume":"22","author":"X Niu","year":"2016","unstructured":"Niu X, Zhao J, Ma J, Xie C, Edwards H, Wang G, Caldwell JT, Xiang S, Zhang X, Chu R, Wang ZJ, Lin H, Taub JW, Ge Y. Binding of released bim to Mcl-1 is a mechanism of intrinsic resistance to ABT-199 which can be overcome by combination with daunorubicin or cytarabine in AML cells. Clin Cancer Res. 2016;22(17):4440\u201351. https:\/\/doi.org\/10.1158\/1078-0432.CCR-15-3057.","journal-title":"Clin Cancer Res"},{"issue":"2","key":"2696_CR40","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1002\/jcc.21334","volume":"31","author":"O Trott","year":"2010","unstructured":"Trott O, Olson AJ. AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem. 2010;31(2):455\u201361. https:\/\/doi.org\/10.1002\/jcc.21334.","journal-title":"J Comput Chem"},{"issue":"11","key":"2696_CR41","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1080\/13543776.2019.1672661","volume":"29","author":"S Fletcher","year":"2019","unstructured":"Fletcher S. MCL-1 inhibitors - where are we now (2019)? Exp Opin Ther Pat. 2019;29(11):909\u201319. https:\/\/doi.org\/10.1080\/13543776.2019.1672661.","journal-title":"Exp Opin Ther Pat"},{"issue":"6","key":"2696_CR42","doi-asserted-by":"publisher","first-page":"2410","DOI":"10.1021\/acs.jmedchem.7b01155","volume":"61","author":"S Shaw","year":"2018","unstructured":"Shaw S, Bian Z, Zhao B, Tarr JC, Veerasamy N, Jeon KO, Belmar J, Arnold AL, Fogarty SA, Perry E, Sensintaffar JL, Camper DV, Rossanese OW, Lee T, Olejniczak ET, Fesik SW. Optimization of potent and selective tricyclic indole diazepinone myeloid cell leukemia-1 inhibitors using structure-based design. J Med Chem. 2018;61(6):2410\u201321. https:\/\/doi.org\/10.1021\/acs.jmedchem.7b01155.","journal-title":"J Med Chem"},{"issue":"11","key":"2696_CR43","doi-asserted-by":"publisher","first-page":"2885","DOI":"10.1021\/acs.jcim.7b00396","volume":"57","author":"J Fogha","year":"2017","unstructured":"Fogha J, Marekha B, De Giorgi M, Voisin-Chiret AS, Rault S, Bureau R. Sopkova-de Oliveira Santos J. toward understanding Mcl-1 promiscuous and specific binding mode. J Chem Inf Model. 2017;57(11):2885\u201395. https:\/\/doi.org\/10.1021\/acs.jcim.7b00396.","journal-title":"J Chem Inf Model"},{"issue":"15","key":"2696_CR44","doi-asserted-by":"publisher","first-page":"2392","DOI":"10.3390\/nu16152392","volume":"16","author":"S Kaur","year":"2024","unstructured":"Kaur S, Mendonca P, Soliman KFA. The anticancer effects and therapeutic potential of kaempferol in triple-negative breast cancer. Nutrients. 2024;16(15):2392. https:\/\/doi.org\/10.3390\/nu16152392.","journal-title":"Nutrients"},{"key":"2696_CR45","doi-asserted-by":"publisher","first-page":"155261","DOI":"10.1016\/j.phymed.2023.155261","volume":"128","author":"Y Pu","year":"2024","unstructured":"Pu Y, Han Y, Ouyang Y, Li H, Li L, Wu X, Yang L, Gao J, Zhang L, Zhou J, Ji Q, Song Q. Kaempferol inhibits colorectal cancer metastasis through circ_0000345 mediated JMJD2C\/\u03b2-catenin signalling pathway. Phytomedicine. 2024;128:155261. https:\/\/doi.org\/10.1016\/j.phymed.2023.155261.","journal-title":"Phytomedicine"},{"key":"2696_CR46","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1186\/s13045-015-0224-3","volume":"8","author":"S Cang","year":"2015","unstructured":"Cang S, Iragavarapu C, Savooji J, Song Y, Liu D. ABT-199 (venetoclax) and BCL-2 inhibitors in clinical development. J Hematol Oncol. 2015;8:129. https:\/\/doi.org\/10.1186\/s13045-015-0224-3.","journal-title":"J Hematol Oncol"},{"issue":"1","key":"2696_CR47","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1186\/s12951-022-01330-y","volume":"20","author":"J Chen","year":"2022","unstructured":"Chen J, Tan Q, Yang Z, Jin Y. Engineered extracellular vesicles: potentials in cancer combination therapy. J Nanobiotechnol. 2022;20(1):132. https:\/\/doi.org\/10.1186\/s12951-022-01330-y.","journal-title":"J Nanobiotechnol"},{"issue":"4","key":"2696_CR48","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1038\/s41591-019-0368-8","volume":"25","author":"KL Bryant","year":"2019","unstructured":"Bryant KL, Stalnecker CA, Zeitouni D, Klomp JE, Peng S, Tikunov AP, Gunda V, Pierobon M, Waters AM, George SD, Tomar G, Papke B, Hobbs GA, Yan L, Hayes TK, Diehl JN, Goode GD, Chaika NV, Wang Y, Zhang GF, Witkiewicz AK, Knudsen ES, Petricoin EF 3rd, Singh PK, Macdonald JM, Tran NL, Lyssiotis CA, Ying H, Kimmelman AC, Cox AD, Der CJ. Combination of ERK and autophagy inhibition as a treatment approach for pancreatic cancer. Nat Med. 2019;25(4):628\u201340. https:\/\/doi.org\/10.1038\/s41591-019-0368-8.","journal-title":"Nat Med"},{"issue":"10073","key":"2696_CR49","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1016\/S0140-6736(16)32409-6","volume":"389","author":"JP Neoptolemos","year":"2017","unstructured":"Neoptolemos JP, Palmer DH, Ghaneh P, Psarelli EE, Valle JW, Halloran CM, Faluyi O, O\u2019Reilly DA, Cunningham D, Wadsley J, Darby S, Meyer T, Gillmore R, Anthoney A, Lind P, Glimelius B, Falk S, Izbicki JR, Middleton GW, Cummins S, Ross PJ, Wasan H, McDonald A, Crosby T, Ma YT, Patel K, Sherriff D, Soomal R, Borg D, Sothi S, Hammel P, Hackert T, Jackson R, Buchler MW. European Study Group for Pancreatic C. Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicentre, open-label, randomised, phase 3 trial. Lancet. 2017;389(10073):1011\u201324. https:\/\/doi.org\/10.1016\/S0140-6736(16)32409-6.","journal-title":"Lancet"},{"issue":"1\u20132","key":"2696_CR50","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1007\/s10495-022-01780-7","volume":"28","author":"D Kaloni","year":"2023","unstructured":"Kaloni D, Diepstraten ST, Strasser A, Kelly GL. BCL-2 protein family: attractive targets for cancer therapy. Apoptosis. 2023;28(1\u20132):20\u201338. https:\/\/doi.org\/10.1007\/s10495-022-01780-7.","journal-title":"Apoptosis"},{"issue":"2","key":"2696_CR51","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1038\/s41419-021-03500-6","volume":"12","author":"N Parry","year":"2021","unstructured":"Parry N, Wheadon H, Copland M. The application of BH3 mimetics in myeloid leukemias. Cell Death Dis. 2021;12(2):222. https:\/\/doi.org\/10.1038\/s41419-021-03500-6.","journal-title":"Cell Death Dis"},{"issue":"5","key":"2696_CR52","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144(5):646\u201374. https:\/\/doi.org\/10.1016\/j.cell.2011.02.013.","journal-title":"Cell"},{"issue":"1","key":"2696_CR53","doi-asserted-by":"publisher","first-page":"128","DOI":"10.3390\/biom10010128","volume":"10","author":"S Banjara","year":"2020","unstructured":"Banjara S, Suraweera CD, Hinds MG, Kvansakul M. The Bcl-2 family: ancient origins, conserved structures, and divergent mechanisms. Biomolecules. 2020;10(1):128. https:\/\/doi.org\/10.3390\/biom10010128.","journal-title":"Biomolecules"},{"issue":"11","key":"2696_CR54","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1038\/s41419-023-06264-3","volume":"14","author":"Z Li","year":"2023","unstructured":"Li Z, Zhou H, Zhai X, Gao L, Yang M, An B, Xia T, Du G, Li X, Wang W, Jin B. MELK promotes HCC carcinogenesis through modulating cuproptosis-related gene DLAT-mediated mitochondrial function. Cell Death Dis. 2023;14(11):733. https:\/\/doi.org\/10.1038\/s41419-023-06264-3.","journal-title":"Cell Death Dis"},{"issue":"9","key":"2696_CR55","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1038\/s41556-024-01429-4","volume":"26","author":"HL Glover","year":"2024","unstructured":"Glover HL, Schreiner A, Dewson G, Tait SWG. Mitochondria and cell death. Nat Cell Biol. 2024;26(9):1434\u201346. https:\/\/doi.org\/10.1038\/s41556-024-01429-4.","journal-title":"Nat Cell Biol"},{"issue":"1","key":"2696_CR56","doi-asserted-by":"publisher","first-page":"e1593","DOI":"10.1038\/cddis.2014.525","volume":"6","author":"GS Choudhary","year":"2015","unstructured":"Choudhary GS, Al-Harbi S, Mazumder S, Hill BT, Smith MR, Bodo J, Hsi ED, Almasan A. MCL-1 and BCL-xL-dependent resistance to the BCL-2 inhibitor ABT-199 can be overcome by preventing PI3K\/AKT\/mTOR activation in lymphoid malignancies. Cell Death Dis. 2015;6(1):e1593. https:\/\/doi.org\/10.1038\/cddis.2014.525.","journal-title":"Cell Death Dis"},{"key":"2696_CR57","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.bbrc.2022.01.019","volume":"593","author":"J Feng","year":"2022","unstructured":"Feng J, Liu P, Li X, Zhang D, Lin H, Hou Z, Guo C, Niu Y, Dai B, Wang O, Qi M, Wang H, Zhou H. The deubiquitinating enzyme USP20 regulates the stability of the MCL1 protein. Biochem Biophys Res Commun. 2022;593:122\u20138. https:\/\/doi.org\/10.1016\/j.bbrc.2022.01.019.","journal-title":"Biochem Biophys Res Commun"},{"issue":"7","key":"2696_CR58","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1038\/nrclinonc.2016.206","volume":"14","author":"EE Manasanch","year":"2017","unstructured":"Manasanch EE, Orlowski RZ. Proteasome inhibitors in cancer therapy. Nat Rev Clin Oncol. 2017;14(7):417\u201333. https:\/\/doi.org\/10.1038\/nrclinonc.2016.206.","journal-title":"Nat Rev Clin Oncol"},{"issue":"1","key":"2696_CR59","doi-asserted-by":"publisher","first-page":"5242","DOI":"10.1038\/s41467-023-40975-7","volume":"14","author":"Z Gong","year":"2023","unstructured":"Gong Z, Zhu J, Chen J, Feng F, Zhang H, Zhang Z, Song C, Liang K, Yang S, Fan S, Fang X, Shen S. CircRREB1 mediates lipid metabolism related senescent phenotypes in chondrocytes through FASN post-translational modifications. Nat Commun. 2023;14(1):5242. https:\/\/doi.org\/10.1038\/s41467-023-40975-7.","journal-title":"Nat Commun"}],"container-title":["Medical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-025-02696-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12032-025-02696-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-025-02696-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T01:58:24Z","timestamp":1746151104000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12032-025-02696-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,1]]},"references-count":59,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2025,5]]}},"alternative-id":["2696"],"URL":"https:\/\/doi.org\/10.1007\/s12032-025-02696-3","relation":{},"ISSN":["1559-131X"],"issn-type":[{"value":"1559-131X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,1]]},"assertion":[{"value":"17 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Generative AI was used to improve the grammar and language of the manuscript only. After using this tool\/service, the author(s) reviewed and edited the content as needed and take(s) full responsibility for the content of the publication.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declaration of generative AI"}}],"article-number":"146"}}